Nanogen Releases Pharmacogenetics Research Reagents for CYP2C9 and VKORC1 Analysis

Nanogen, Inc. announced that it has released reagents designed for research use only studies analyzing CYP2C9 and VKORC1, two genes with potential applications in drug metabolism and response. The company plans to submit similar reagents, along with others, for FDA clearance in 2007.

Source: Nanogen